Genetic Modifiers of Cardiovascular Phenotype Caused by Elastin Haploinsufficiency Act by Extrinsic Noncomplementation*

Background: Variability in vascular pathology is associated with elastin loss-of-function mutations. Results: Quantitative trait loci and several candidate genes that modify vessel pathology were identified in a mouse model of elastin insufficiency. Conclusion: The effects of elastin insufficiency are determined by interactions between the primary elastin defect and unrelated secondary modifiers. Significance: Identification of modifier genes enhances our understanding of disease mechanisms associated with elastin mutations. Elastin haploinsufficiency causes the cardiovascular complications associated with Williams-Beuren syndrome and isolated supravalvular aortic stenosis. Significant variability exists in the vascular pathology in these individuals. Using the Eln+/− mouse, we sought to identify the source of this variability. Following outcrossing of C57Bl/6J Eln+/−, two backgrounds were identified whose cardiovascular parameters deviated significantly from the parental strain. F1 progeny of the C57Bl/6J; Eln+/−x129X1/SvJ were more hypertensive and their arteries less compliant. In contrast, Eln+/− animals crossed to DBA/2J were protected from the pathologic changes associated with elastin insufficiency. Among the crosses, aortic elastin and collagen content did not correlate with quantitative vasculopathy traits. Quantitative trait locus analysis performed on F2 C57; Eln+/−x129 intercrosses identified highly significant peaks on chromosome 1 (LOD 9.7) for systolic blood pressure and on chromosome 9 (LOD 8.7) for aortic diameter. Additional peaks were identified that affect only Eln+/−, including a region upstream of Eln on chromosome 5 (LOD 4.5). Bioinformatic analysis of the quantitative trait locus peaks revealed several interesting candidates, including Ren1, Ncf1, and Nos1; genes whose functions are unrelated to elastic fiber assembly, but whose effects may synergize with elastin insufficiency to predispose to hypertension and stiffer blood vessels. Real time RT-PCR studies show background-specific increased expression of Ncf1 (a subunit of the NOX2 NAPDH oxidase) that parallel the presence of increased oxidative stress in Eln+/− aortas. This finding raises the possibility that polymorphisms in genes affecting the generation of reactive oxygen species alter cardiovascular function in individuals with elastin haploinsufficiency through extrinsic noncomplementation.

[1]  Mark T Gladwin,et al.  Oxidases and peroxidases in cardiovascular and lung disease: new concepts in reactive oxygen species signaling. , 2011, Free radical biology & medicine.

[2]  Tom R. Gaunt,et al.  Genetic Variants in Novel Pathways Influence Blood Pressure and Cardiovascular Disease Risk , 2011, Nature.

[3]  G. Mercuro,et al.  Increased arterial stiffness in children with Williams syndrome and normal blood pressure , 2010, Blood pressure monitoring.

[4]  V. Lemos,et al.  Relative contribution of eNOS and nNOS to endothelium-dependent vasodilation in the mouse aorta. , 2010, European journal of pharmacology.

[5]  K. Griendling,et al.  NADPH Oxidases: Functions and Pathologies in the Vasculature , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[6]  H. Tomita,et al.  Aortic Arch Curvature and Atherosclerosis Have Overlapping Quantitative Trait Loci in a Cross Between 129S6/SvEvTac and C57BL/6J Apolipoprotein E-Null Mice , 2010, Circulation research.

[7]  B. Pober.  Williams-Beuren syndrome. , 2010, The New England journal of medicine.

[8]  A. Shah,et al.  Neuronal Nitric Oxide Synthase and Human Vascular Regulation , 2009, Trends in cardiovascular medicine.

[9]  G. Churchill,et al.  Genetic Analysis of Blood Pressure in 8 Mouse Intercross Populations , 2009, Hypertension.

[10]  R. Mecham,et al.  Vascular extracellular matrix and arterial mechanics. , 2009, Physiological reviews.

[11]  H. Pei,et al.  Quantitative Trait Locus Analysis of Neointimal Formation in an Intercross Between C57BL/6 and C3H/HeJ Apolipoprotein E–Deficient Mice , 2009, Circulation. Cardiovascular genetics.

[12]  R. Knutsen,et al.  Reduced Vessel Elasticity Alters Cardiovascular Structure and Function in Newborn Mice , 2009, Circulation research.

[13]  R. Knutsen,et al.  Upregulation of elastase proteins results in aortic dilatation in mucopolysaccharidosis I mice. , 2008, Molecular genetics and metabolism.

[14]  Benjamin S. Brooke,et al.  Angiotensin II blockade and aortic-root dilation in Marfan's syndrome. , 2008, The New England journal of medicine.

[15]  B. Pober,et al.  Mechanisms and treatment of cardiovascular disease in Williams-Beuren syndrome. , 2008, The Journal of clinical investigation.

[16]  D. Marchuk,et al.  Hypertension and albuminuria in chronic kidney disease mapped to a mouse chromosome 11 locus. , 2007, Kidney international.

[17]  Hideki Sugitani,et al.  Functional Rescue of Elastin Insufficiency in Mice by the Human Elastin Gene: Implications for Mouse Models of Human Disease , 2007, Circulation research.

[18]  Marc K. Halushka,et al.  Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan Syndrome , 2006, Science.

[19]  M. Bayés,et al.  Hemizygosity at the NCF1 gene in patients with Williams-Beuren syndrome decreases their risk of hypertension. , 2006, American journal of human genetics.

[20]  D. Marchuk,et al.  QTL mapping in a mouse model of cardiomyopathy reveals an ancestral modifier allele affecting heart function and survival , 2005, Mammalian Genome.

[21]  Dean Y. Li,et al.  Effects of elastin haploinsufficiency on the mechanical behavior of mouse arteries. , 2005, American journal of physiology. Heart and circulatory physiology.

[22]  S. Lyonnet,et al.  Vascular Wall Remodeling in Patients with Supravalvular Aortic Stenosis and Williams Beuren Syndrome , 2005, Journal of Vascular Research.

[23]  M. Massett,et al.  Strain-dependent differences in responses to exercise training in inbred and hybrid mice. , 2005, American journal of physiology. Regulatory, integrative and comparative physiology.

[24]  M. Bihoreau,et al.  Chromosomal Mapping of Quantitative Trait Loci Controlling Elastin Content in Rat Aorta , 2005, Hypertension.

[25]  Hongtao Zhao,et al.  Superoxide reacts with hydroethidine but forms a fluorescent product that is distinctly different from ethidium: potential implications in intracellular fluorescence detection of superoxide. , 2003, Free radical biology & medicine.

[26]  Charles R Cantor,et al.  A high-throughput gene expression analysis technique using competitive PCR and matrix-assisted laser desorption ionization time-of-flight MS , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[27]  M. Ebaid,et al.  Arterial hypertension in a child with Williams-Beuren syndrome (7q11.23 chromosomal deletion). , 2002, Arquivos brasileiros de cardiologia.

[28]  E. Kitamura,et al.  Characterization of FAM10A4, a member of the ST13 tumor suppressor gene family that maps to the 13q14.3 region associated with B-Cell leukemia, multiple myeloma, and prostate cancer. , 2002, Genomics.

[29]  A. Banerjee,et al.  Evaluation of arterial stiffness in children with Williams syndrome: Does it play a role in evolving hypertension? , 2001, American heart journal.

[30]  B. Garvik,et al.  Principles for the buffering of genetic variation. , 2001 .

[31]  C. Cytrynbaum,et al.  Elastin: mutational spectrum in supravalvular aortic stenosis , 2000, European Journal of Human Genetics.

[32]  J Kachaner,et al.  Mechanical properties of the common carotid artery in Williams syndrome , 2000, Heart.

[33]  Dean Y. Li,et al.  Relation between outer and luminal diameter in cannulated arteries. , 1999, American journal of physiology. Heart and circulatory physiology.

[34]  W. Tamborlane,et al.  Elevated ambulatory blood pressure in 20 subjects with Williams syndrome. , 1999, American journal of medical genetics.

[35]  R. Mecham,et al.  Novel arterial pathology in mice and humans hemizygous for elastin. , 1998, The Journal of clinical investigation.

[36]  Dean Y. Li,et al.  Elastin is an essential determinant of arterial morphogenesis , 1998, Nature.

[37]  E. Lander,et al.  Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results , 1995, Nature Genetics.

[38]  R. Mecham,et al.  Identification of an Elastin Cross-linking Domain That Joins Three Peptide Chains , 1995, The Journal of Biological Chemistry.

[39]  C A Morris,et al.  Supravalvular aortic stenosis associated with a deletion disrupting the elastin gene. , 1994, The Journal of clinical investigation.

[40]  J. Roder,et al.  Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[41]  Colleen A. Morris,et al.  The elastin gene is disrupted by a translocation associated with supravalvular aortic stenosis , 1993, Cell.

[42]  D. Jackson,et al.  THE CHANGES IN CHEMICAL COMPOSITION DURING DEVELOPMENT OF THE BOVINE NUCHAL LIGAMENT , 1967, The Journal of cell biology.

[43]  D. Harrison,et al.  Detection of reactive oxygen species and nitric oxide in vascular cells and tissues: comparison of sensitivity and specificity. , 2007, Methods in molecular medicine.

[44]  Webb Miller,et al.  Generation and Comparative Analysis of ∼3.3 Mb of Mouse Genomic Sequence Orthologous to the Region of Human Chromosome 7q11.23 Implicated in Williams Syndrome , 2002 .

[45]  C A Morris,et al.  Williams syndrome and related disorders. , 2000, Annual review of genomics and human genetics.

[46]  J. Foster,et al.  Elastin gene expression. , 1983, International review of connective tissue research.